In 2014, the U.S. Food and Drug Administration (FDA) published a statement discouraging the use of power morcellators during procedures to remove uterine fibroids. As a result, many morcellator sellers ceased manufacturing the devices and their use has drastically declined. However, Olympus America Inc. recently launched a new bladeless morcellator that is meant to prevent the inadvertent spreading of cancerous cells. Despite these changes, the FDA required the company to include a warning on the device‚Äôs label explaining that the instrument has not been proven to reduce the risk of spreading cancer.… Read More